Otros idiomas Tuoxin Pharmaceutical Group Co.,Ltd.

Acciones

301089

CNE100004YC3

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
33,5 ^CNY	-.--%		-10,50 %	-37,97 %

22/04	Tuoxin Pharmaceutical Group Co.,Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
22/04	Tuoxin Pharmaceutical Group Co.,Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Tuoxin Pharmaceutical Group Co.,Ltd.(XSEC:301089) added to S&P Global BMI Index	18/09/23
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 06 June 2023	31/05/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. has Changed its Name to Tuoxin Pharmaceutical Group Co., Ltd	26/05/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022	18/05/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year of 2022	26/04/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23
Xinxiang Tuoxin Pharma to Form New Chemical Products Subsidiary	17/03/23
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	20/10/22
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 25, 2022	18/05/22
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2021	17/05/22
Tuoxin Pharmaceutical to Free Up 1.5 Million Shares For Trading; Shares Tank 5%	26/04/22
Xinxiang Tuoxin Pharma’s 2021 Profit Plunges 42% as Sales Slip 5%	25/04/22
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2021	22/04/22
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/04/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tuoxin Pharmaceutical Group Co.,Ltd.

Acciones

301089

CNE100004YC3

Otros idiomas

Filtros